Yamada Y, Wang Y, Liu H, Gerongano G, Tseng C, Liu S
Virol J. 2025; 22(1):50.
PMID: 40001231
PMC: 11863438.
DOI: 10.1186/s12985-025-02672-3.
Reguzova A, Muller M, Pagallies F, Burri D, Salomon F, Rziha H
NPJ Vaccines. 2024; 9(1):191.
PMID: 39414789
PMC: 11484955.
DOI: 10.1038/s41541-024-00981-2.
Metz C, Haug V, Muller M, Amann R
Vaccines (Basel). 2024; 12(5).
PMID: 38793743
PMC: 11126055.
DOI: 10.3390/vaccines12050492.
Pagallies F, Labisch J, Wronska M, Pflanz K, Amann R
Vaccine X. 2024; 18:100474.
PMID: 38523620
PMC: 10958475.
DOI: 10.1016/j.jvacx.2024.100474.
Gao K, Li H, Lei X, Sun Z, Zheng T, Chen M
Vet Res Commun. 2023; 47(4):2071-2081.
PMID: 37421550
DOI: 10.1007/s11259-023-10169-z.
A Summary of Practical Considerations for the Application of the Steric Exclusion Chromatography for the Purification of the Orf Viral Vector.
Eilts F, Lothert K, Orbay S, Pagallies F, Amann R, Wolff M
Membranes (Basel). 2022; 12(11).
PMID: 36363625
PMC: 9696199.
DOI: 10.3390/membranes12111070.
Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses.
Muller M, Reguzova A, Loffler M, Amann R
Front Immunol. 2022; 13:873351.
PMID: 35615366
PMC: 9124846.
DOI: 10.3389/fimmu.2022.873351.
A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study.
Reguzova A, Fischer N, Muller M, Salomon F, Jaenisch T, Amann R
Biomedicines. 2021; 9(12).
PMID: 34944678
PMC: 8698572.
DOI: 10.3390/biomedicines9121862.
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy.
van Vloten J, Minott J, McAusland T, Ingrao J, Santry L, McFadden G
Mol Ther Methods Clin Dev. 2021; 23:434-447.
PMID: 34786436
PMC: 8579082.
DOI: 10.1016/j.omtm.2021.08.004.
NF-κB as an Important Factor in Optimizing Poxvirus-Based Vaccines against Viral Infections.
Struzik J, Szulc-Dabrowska L
Pathogens. 2020; 9(12).
PMID: 33260450
PMC: 7760304.
DOI: 10.3390/pathogens9121001.
Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector.
Lothert K, Pagallies F, Feger T, Amann R, Wolff M
J Biotechnol. 2020; 323:62-72.
PMID: 32763261
PMC: 7403136.
DOI: 10.1016/j.jbiotec.2020.07.023.
Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.
Schneider M, Muller M, Yigitliler A, Xi J, Simon C, Feger T
J Virol. 2020; 94(15).
PMID: 32404527
PMC: 7375371.
DOI: 10.1128/JVI.00398-20.
Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease.
Rall I, Amann R, Malberg S, Herden C, Rubbenstroth D
Viruses. 2019; 11(12).
PMID: 31817690
PMC: 6950018.
DOI: 10.3390/v11121130.
Establishment and characterization of transformed goat primary cells by expression of simian virus 40 large T antigen for orf virus propagations.
Yamada Y, Liao G, Tseng C, Tseng Y, Hsu W
PLoS One. 2019; 14(12):e0226105.
PMID: 31805146
PMC: 6894772.
DOI: 10.1371/journal.pone.0226105.
Genomic Characterization of Strain D1701-V () and Development of Novel Sites for Multiple Transgene Expression.
Rziha H, Buttner M, Muller M, Salomon F, Reguzova A, Laible D
Viruses. 2019; 11(2).
PMID: 30704093
PMC: 6409557.
DOI: 10.3390/v11020127.
